GSK (GSK) stock slips as FDA advisors vote against the approval of a combination regimen involving thecompany's blood cancer drug Blenrep. Read more here.

Texas Capital Bancshares posts record Q2 2025 growth with 16% revenue rise, 100% income surge, & robust loan expansion.

Learn why FITB's credit risk has stabilized but challenges in deposits, net interest margin, and valuation make it a cautious ...

Opendoor’s meme-fueled rally is partly backed by subtle macroenvironment relief and a strategic shift. Read why I think OPEN ...

Adient is a global leader in automotive seating but lacks a dividend yield and has a poor track record of meeting earnings ...

PepsiCo faces weak volume trends, high debt, and growth challenges despite an earnings beat. Read why I see better ...

Fifth Third Bancorp beats Q2 2025 estimates with strong loan growth, raised NII guidance, and resilient balance sheet.

In today’s equity market, mega-cap stocks are not just influential—they have become a driving force shaping overall ...

This monthly article series provides a top-down analysis of the consumer staples sector based on value, quality, and momentum ...

Discover why El Pollo Loco's rating shifts from 'buy' to 'hold' amid declining traffic, slowed sales growth, and rising costs ...

CuriosityStream (CURI) stock pulls back after earnings surge. Insider selling and AI strategy raise concerns, but guidance hints at future growth.

Click to explore why the bullish sentiment on AGNC Investment Corp. might be premature, with insights on risks like yield ...